NEWS CENTER
Your current location:
Home
-
News Center

NEWS CENTER

The worldwide first product caIMR of RainMed entered the green channel of innovative medical devices and accelerated the commercialization
2022-04-20

The worldwide first product caIMR of RainMed entered the green channel of innovative medical devices and accelerated the commercialization

Recently, RainMed Medical Coronary Function Measurement System (hereinafter referred to as "RainMed caIMR") has successfully entered the special approval channel for innovative medical devices of NMPA, and has obtained the priority of NMPA certification. As the world's leading non-interventional microcirculation diagnosis system, the approval of caIMR fully reflects the international leadership of its technology and its superior clinical value.   The approval of the innovative application of caIMR will accelerate its commercialization, accelerate the opening of tens of billions of blue ocean market for microcirculation diagnosis, and lead the cardiovascular field into a new era of comprehensive assessment of myocardial functional ischemia. It also lays a key foundation for RainMed Medical to build a vascular interventional surgery robot covering the whole process of comprehensive diagnosis and treatment. Announcement of the review results of the special application for innovative medical devices   As a green channel for medical device approval, the special approval channel for innovative medical devices has a high approval threshold and a very low approval rate. Since the implementation of the approval process in 2014, only 170 products have been approved in China and the approval rate is only 20%. Among them, the caIMR and caFFR of RainMed and their supporting supplies have been successfully approved to enter the green channel of innovative medical devices, demonstrating RainMed Medical's excellent innovative R&D capabilities.   Preferential policy support and excellent clinical results jointly help RainMed to accelerate the commercialization of caIMR In the process of coronary heart disease diagnosis and treatment, IMR evaluation has important clinical significance and has been widely recommended by domestic and foreign guidelines. Data show that 40% of patients with coronary artery disease still suffer from recurrent angina after PCI, partly due to microcirculatory dysfunction. Therefore, guidelines such as "Guidelines for Diagnosis and Management of Chronic Coronary Syndrome", "Chinese Expert Consensus on Diagnosis and Treatment of Coronary Microvascular Diseases (2017)", "Chinese Multidisciplinary Expert Consensus on Diagnosis and Treatment of Microvascular Diseases (2020)" and other guidelines all recommend IMR assessment in patients with coronary heart disease. caIMR of RainMed caIMR of RainMed has made up for the deficiencies of traditional guide wire-derived IMR detection, and offered more practical clinical detection methods to coronary microcirculation. In the past, guide wire-derived IMR measurement requires the use of hyperemic agents and repeated injection of normal saline, which takes a long time to measure IMR and has a high risk and therefore it is only suitable for clinical research. caIMR does not require the pressure guide wire and hyperemic agents. It does not need to change the surgeon's surgical habits. It only takes an average of 5 minutes to measure IMR based on angiograms, blood flow velocity by TIMI frame count, real-time aortic pressure and a specially-designed CFD model. It is safe, efficient and simple, and offers a new opportunity to promote the large-scale clinical application of coronary microcirculation assessment.   As the world's first diagnostic method for coronary microcirculation function in the confirmatory clinical trial stage, RainMed caIMR was successfully approved to enter the green channel of innovative medical devices, bringing sufficient confidence to accelerate the large-scale clinical application of the product.   As of December 2021, RainMed caIMR has successfully completed the clinical enrollment of the confirmatory trial. The study is led by Zhongshan Hospital Affiliated to Fudan University with the top cardiology experts academician Ge Junbo and Professor Huo Yong of Peking University First Hospital as PI. At present, caIMR has achieved excellent clinical research results and has successfully entered the registration clinical stage. caIMR confirmatory clinical research launch ceremony The preferential policies and assistance to high-innovation medical devices given by the state and the confirmatory clinical results that exceeded expectations have brought more confidence to accelerate the commercialization of caIMR. It is believed that the large-scale clinical application of caIMR will surely improve the level of diagnosis and treatment of coronary artery disease and lead coronary artery disease into a new era of precision medicine.    Top SCI journals confirm that caIMR of RainMed has a wide range of clinical indications and excellent clinical application value The global initiative of RainMed caIMR has attracted extensive attention from well-known experts at home and abroad, and has become a hot topic of international clinical research. A number of blockbuster research papers published in SCI journals have made detailed demonstra
See more
Huihui Wu, Deputy Director of Suzhou Industrial Park Administrative Committee, Visited RainMed Medical to Provide More Support for the Development of High-tech Medical Enterprises.
2023-10-19

Huihui Wu, Deputy Director of Suzhou Industrial Park Administrative Committee, Visited RainMed Medical to Provide More Support for the Development of High-tech Medical Enterprises.

Huihui Wu, Deputy Director of Suzhou Industrial Park Administrative Committee, Visited RainMed Medical to Provide More Support for the Development of High-tech Medical Enterprises.
See more
Xinhua Net Interview | Mr. Kangjian Liu: Precision Diagnosis and Treatment Services for Public Health, and Lean Management Enhances Enterprise Efficiency
2023-10-13

Xinhua Net Interview | Mr. Kangjian Liu: Precision Diagnosis and Treatment Services for Public Health, and Lean Management Enhances Enterprise Efficiency

Recently, RainMed Medical was invited by Xinhua Net to participate in the Entrepreneur Annual Conference Interview. Mr. Kangjian Liu, Vice President and Secretary of the Board of Directors of the company, represented RainMed for the interview.
See more
RainMed Medical Successfully Held the Launch Meeting of WMS Intelligent Warehousing Project to Further Optimized Its Customer Service Level
2023-09-28

RainMed Medical Successfully Held the Launch Meeting of WMS Intelligent Warehousing Project to Further Optimized Its Customer Service Level

RainMed Medical Successfully Held the Launch Meeting of WMS Intelligent Warehousing Project to Further Optimized Its Customer Service Level
See more
RainMed Medical and Dushu Lake Hospital Affiliated to Soochow University Have Signed a Strategic Cooperation Agreement to Promote High-quality Hospital-enterprise Cooperation.
2023-09-22

RainMed Medical and Dushu Lake Hospital Affiliated to Soochow University Have Signed a Strategic Cooperation Agreement to Promote High-quality Hospital-enterprise Cooperation.

RainMed Medical and Dushu Lake Hospital Affiliated to Soochow University Have Signed a Strategic Cooperation Agreement to Promote High-quality Hospital-enterprise Cooperation.
See more
Chairman Yaping Li and His Delegation from the Standing Committee of Suzhou Municipal People
2023-09-08

Chairman Yaping Li and His Delegation from the Standing Committee of Suzhou Municipal People's Congress Visited RainMed Medical, Fully Affirming the Domestic Independent Innovation in Medical Technology.

Chairman Yaping Li and his delegation from the Standing Committee of Suzhou Municipal People's Congress visited RainMed Medical, fully afirming the domestic independent innovation in medical technology.
See more
Secretary of the Foshan Municipal Party Committee Ke Zheng Led a Delegation of Government Officials on a Visit to RainMed Medical to Feel the Robust Development of the Medical Industry
2023-08-11

Secretary of the Foshan Municipal Party Committee Ke Zheng Led a Delegation of Government Officials on a Visit to RainMed Medical to Feel the Robust Development of the Medical Industry

Secretary of the Foshan Municipal Party Committee Ke Zheng Led a Delegation of Government Officials on a Visit to RainMed Medical to Feel the Robust Development of the Medical Industry.
See more
The Expert Team of Beijing Anzhen Hospital Further Confirmed That RainMed Medical’s caIMR System Can Immediately Recognize and Predict the Occurrence and Evolution of Microvascular Injury in Patients After PPCI
2023-08-04

The Expert Team of Beijing Anzhen Hospital Further Confirmed That RainMed Medical’s caIMR System Can Immediately Recognize and Predict the Occurrence and Evolution of Microvascular Injury in Patients After PPCI

The Expert Team of Beijing Anzhen Hospital Further Confirmed That RainMed Medical’s caIMR System Can Immediately Recognize and Predict the Occurrence and Evolution of Microvascular Injury in Patients After PPCI
See more
Award | RainMed Medical Was Awarded the “Pioneering Enterprise of Independent Innovation” and "Law-abiding and Honest Enterprise" in the "2022-2023 China Medical Industry Most Influential List".
2023-07-28

Award | RainMed Medical Was Awarded the “Pioneering Enterprise of Independent Innovation” and "Law-abiding and Honest Enterprise" in the "2022-2023 China Medical Industry Most Influential List".

Recently, the All-China Federation of Industry and Commerce announced the "2022-2023 China Medical Industry Most Influential List" at the China Medical Industry Development Forum. After a two-month evaluation process, RainMed Medical stood out among more than 1,000 participating companies and was awarded the “Pioneering Enterprise of Independent Innovation” and "Law-abiding and Honest Enterprise" honors along with leading companies in the industry such as HENGRUI, United Imaging Healthcare, and LEPU.
See more
RainMed Was Invited to Attend 2023 China Medical Device Intellectual Property Development Summit Forum to Promote the Development and Cooperation of Medical Device Intellectual Property Rights with Top 100 Medical Device Companies From Home and Abroad
2023-07-21

RainMed Was Invited to Attend 2023 China Medical Device Intellectual Property Development Summit Forum to Promote the Development and Cooperation of Medical Device Intellectual Property Rights with Top 100 Medical Device Companies From Home and Abroad

RainMed Was Invited to Attend 2023 China Medical Device Intellectual Property Development Summit Forum to Promote the Development and Cooperation of Medical Device Intellectual Property Rights with Top 100 Medical Device Companies From Home and Abroad
See more
Award | RainMed Medical
2023-06-30

Award | RainMed Medical's caIMR System was Awarded the "Gold Wish Award·Optimal Solution for Operating Room Efficiency" by CN-Healthcare

Recently, after a two-month review process, the second "Gold Wish Award" optimal solution rank, hosted by CN-Healthcare, was released at the 5th China Medical Innovation Summit. After strict screening by 50 authoritative experts, RainMed Medical's caIMR system emerged among nearly 100 operating room solutions and was awarded the optimal solution for operating rooms along with other high-quality companies in the industry such as MicroPort and InferVersion. The judging experts stated that RainMed Medical's caIMR system can solve the problems of guidewire-derived IMR assessment technology, improve the clinical diagnosis level of coronary microcirculation function, and has solid theoretical foundation and strong operability, making it an optimal solution for improving operating room efficiency.
See more
SCC 2023 | RainMed Medical • "Recent Progress with Innovation" Coronary Physiology Forum Was Successfully Held
2023-06-16

SCC 2023 | RainMed Medical • "Recent Progress with Innovation" Coronary Physiology Forum Was Successfully Held

On June 10, 2023, RainMed Medical successfully hosted the “Recent Progress with Innovation” Coronary Physiology Satellite Symposium during the 24th South China International Congress of Cardiology (SCC 2023). The symposium invited renowned cardiovascular specialists in China to exchange ideas on the technological advancements and clinical applications of coronary functional studies. The innovative coronary microcirculation functional assessment caIMR system, developed by RainMed Medical, was also showcased for its application in daily diagnosis and clinical research.
See more
Leaders From the “China Association for Promotion of Health Science and Technology” and “China Health Promotion Foundation” Visited RainMed Medical to Strongly Support the Development of Domestic High-tech Medical Equipment Enterprises
2023-06-09

Leaders From the “China Association for Promotion of Health Science and Technology” and “China Health Promotion Foundation” Visited RainMed Medical to Strongly Support the Development of Domestic High-tech Medical Equipment Enterprises

Recently, Secretary-General Cencan Xia, Director Duan Zhao, and Director Genxing Shen from China Association for Promotion of Health Science and Technology, as well as Secretary-General Guoying Chen from the China Health Promotion Foundation visited RainMed Medical's Beijing office. During the visit, they expressed their high recognition and appreciation for RainMed’s persistent spirit of innovation and entrepreneurship, as well as its high-quality output. Professor Yunlong Huo, founding shareholder of RainMed Medical and professor of Shanghai Jiao Tong University School of Life Science and Biotechnology, accompanied the delegation along with Liang Wan, Director of RainMed’s Government Affairs Department.
See more
OCC 2023 | RainMed Medical • "Recent Progress in Medical Innovations" Coronary Physiology Forum Was Successfully Held
2023-06-02

OCC 2023 | RainMed Medical • "Recent Progress in Medical Innovations" Coronary Physiology Forum Was Successfully Held

OCC 2023 | RainMed Medical • "Recent Progress in Medical Innovations" Coronary Physiology Forum Was Successfully Held
See more
EuroPCR2023 | RainMed and SINOMED Made Their First Joint Appearance at the World Cardiovascular Conference, Bringing a New Collaborative Concept for Optimized Diagnosis and Treatment of Coronary Artery PCI
2023-05-24

EuroPCR2023 | RainMed and SINOMED Made Their First Joint Appearance at the World Cardiovascular Conference, Bringing a New Collaborative Concept for Optimized Diagnosis and Treatment of Coronary Artery PCI

From May 16 to 19, 2023, RainMed Medical, an innovative medical device listed company from China, joined forces with its strategic partner SINOMED, a leading enterprise in the field of cardiovascular disease treatment, to showcase their original "Redefine PCI" collaborative concept at EuroPCR2023, a global academic conference for interventional cardiovascular medicine. The concept aims to provide tailored solutions for PCI procedures to optimize daily practice and bring optimized diagnostic and therapeutic solutions for coronary artery PCI.
See more
The CCIF 2023 | RainMed Medical • "Medicine Progresses with Innovation" Coronary Physiology Symposium Was Successfully Held
2023-05-12

The CCIF 2023 | RainMed Medical • "Medicine Progresses with Innovation" Coronary Physiology Symposium Was Successfully Held

On April 22, 2023, RainMed Medical successfully held the "Medicine Progresses with Innovation" Coronary Physiology Symposium at the 26th China Cardiology Intervention Forum (CCIF 2023). In order to promote the diagnostic concepts of coronary physiology evaluation and the clinical application of computed coronary physiology indicators, RainMed invited well-known experts in cardiovascular field to the symposium to discuss the latest advancements in the evaluation of coronary physiology and to explore the application prospects of innovative computed coronary physiology indicators, caFFR and caIMR systems.
See more
RainMed Medical Was Selected as "One of the First Demonstration Units of Trade Secret Protection in Suzhou"
2023-05-06

RainMed Medical Was Selected as "One of the First Demonstration Units of Trade Secret Protection in Suzhou"

RainMed Medical Was Selected as "One of the First Demonstration Units of Trade Secret Protection in Suzhou"
See more
Paper Summary of RainMed
2023-04-28

Paper Summary of RainMed's caFFR & caIMR (2)

Paper Summary of RainMed's caFFR and caIMR (2)
See more
Paper Summary of RainMed
2023-04-21

Paper Summary of RainMed's caFFR & caIMR (1)

Paper Summary of RainMed's caFFR & caIMR (1)
See more
RainMed Medical Has Been Comprehensively Promoting the Business Integration of Your Health to Jointly Start a New Journey of Precision Diagnosis and Treatment
2023-04-12

RainMed Medical Has Been Comprehensively Promoting the Business Integration of Your Health to Jointly Start a New Journey of Precision Diagnosis and Treatment

Suzhou RainMed Medical Technology Co., Ltd.(hereinafter referred to as "RainMed") has officially completed the acquisition of Tianjin Your Health Biotechnology Co., Ltd. (hereinafter referred to as "Your Health"). Recently, Yunfei Huo, Chairman of the Board of Directors, Executive Director and CEO of RainMed, Yonghui Lv, Executive Director and co-CEO of RainMed, and Zhibo He, General Manager of Your Health, have made business connections and integration on behalf of both sides. In the future, the two sides will make full use of their technological resources to develop cutting-edge in vitro diagnostic products, and jointly start a new journey of precision medicine.
See more
RainMed Medical was Invited to Attend China-Uzbekistan Medical Cooperation and Development Forum to Promote Health Collaboration Between Medical Enterprises of the Two Countries
2023-04-07

RainMed Medical was Invited to Attend China-Uzbekistan Medical Cooperation and Development Forum to Promote Health Collaboration Between Medical Enterprises of the Two Countries

At the end of March 2023, the China-Uzbekistan Medical Cooperation and Development Forum, co-sponsored by China Chamber of Commerce for Import & Export of Medicines & Health Products and the Pharmaceutical Development Bureau of Investment, Industry and Trade of Uzbekistan, and co-hosted by China-Central Asia Health Industry Alliance and China Meheco Group Co., LTD., was successfully held in Beijing. More than 50 representatives from well-known enterprises from China and Uzbekistan attended the conference. RainMed Medical was also invited to participate. At the conference, the participating enterprises had a lively discussion on the medical and health cooperation between the two countries, making new contributions to the new development of medical industry.
See more
RainMed Medical Has Donated Its Precision Diagnostic Products to Chinese Primary Health Care Foundation to Promote the Benifit of Medical Science and Technology Among the Grassroots
2023-03-24

RainMed Medical Has Donated Its Precision Diagnostic Products to Chinese Primary Health Care Foundation to Promote the Benifit of Medical Science and Technology Among the Grassroots

On March 9th, 2023, RainMed Medical donated dozens of sets of coronary angiography-derived fractional flow reserve measurement systems to Chinese Primary Health Care Foundation. Hui Wang, Deputy Secretary-General of the Foundation, and Yonghui Lv, Executive Director and co-CEO of RainMed Medical, signed the donation cooperation agreement on behalf of both sides. Professor Zheng Zhang from Beijing well-known Class A hospital attended and witnessed the signing ceremony. This donation will help bring high-quality medical resources to the grassroots, promote the development of coronary artery precision diagnosis and treatment, and implement the hierarchical diagnosis and treatment system.
See more
Suzhou RainMed Medical Technology Co., Ltd. Will Acquire a 68.32% Stake in Tianjin Your Health Biotechnology Co., Ltd. to Extend Its Precision Diagnostic Product Pipeline
2023-03-17

Suzhou RainMed Medical Technology Co., Ltd. Will Acquire a 68.32% Stake in Tianjin Your Health Biotechnology Co., Ltd. to Extend Its Precision Diagnostic Product Pipeline

RainMed Medical-B (02297.HK) announced that on March 1st, 2023, Suzhou RainMed Medical Technology Co., Ltd. (hereinafter referred to as "RainMed") will acquire a 68.32% stake in Tianjin Your Health Biotechnology Co., Ltd. (hereinafter referred to as "Your Health") at a total cost of RMB 25.96 million. This strategic merger and acquisition has extended RainMed’s precision diagnosis product pipeline from "covering the whole procedure of PCI" to "inspection on admission" and "inspection at the bedside", providing new momentum for its long-term development.
See more
LATEST! RainMed
2023-03-10

LATEST! RainMed's caFFR System Has Been Commercialized in Serbia, Accelerating the Overall Process of Overseas Commercialization

In February 2023, RainMed's caFFR was commercially launched in the Republic of Serbia and successfully completed its first charging case in Serbia’s national institute of cardiovascular diseases, KBC Dr Dragisa Misovic-Dedinje.
See more
RainMed Medical and SINOMED Signed a Strategic Collaboration Agreement to Jointly Promote the Development of Precision Medicine
2023-03-03

RainMed Medical and SINOMED Signed a Strategic Collaboration Agreement to Jointly Promote the Development of Precision Medicine

On February 28, 2023, RainMed Medical (stock code: 2297.HK) and SINOMED (stock code: 688108.SH) held a strategic collaboration agreement signing ceremony in Beijing. Mr. Yunfei Huo, chairman of the board, executive director and CEO of RainMed Medical, and Mr. Jianhua Sun, chairman and CEO of SINOMED, signed the agreement on behalf of both parties. Professor Yong Huo from Peking University First Hospital, and Professor Yunlong Huo, Co-founding shareholder of RainMed Medical and professor of School of Life Science and Biotechnology of Shanghai Jiao Tong University, also attended the meeting.
See more
RainMed Medical is Applying for MDSAP to Accelerate Its Layout of International Marketing System
2023-02-24

RainMed Medical is Applying for MDSAP to Accelerate Its Layout of International Marketing System

Recently, RainMed Medical is applying for MDSAP (Medical Device Single Audit Program). It is expected that the MDSAP certification issued by international authoritative certification body will further lay the foundation for RainMed's global development strategy.
See more
RainMed Medical was Delighted to Welcome Qiao Zhang, Deputy Mayor of Suzhou, to Investigate and Support the Independent Innovation and Development of Domestic Medical Technology
2023-02-17

RainMed Medical was Delighted to Welcome Qiao Zhang, Deputy Mayor of Suzhou, to Investigate and Support the Independent Innovation and Development of Domestic Medical Technology

Recently, Qiao Zhang, deputy mayor of Suzhou Government, deputy chairman of Jiangsu Committee of Chinese Peasants’ and Workers’ Democratic Party,chairman of Suzhou Committee of Chinese Peasants’ and Workers’ Democratic Party, made a field investigation of RainMed. He had a discussion on the independent innovation of domestic medical devices with Yunfei Huo, chairman of the board of directors, executive director and CEO of RainMed Medical. Kangjian Liu, vice president and secretary of the board of directors of RainMed, introduced RainMed's development strategy and core products. Yang Gu, vice president of RainMed and Chang Zhou accompanied them during the investigation. Hong Sun, deputy director of Suzhou Bureau of Industry and Information Technology; Jianhong Zhang, secondary researcher and full-time deputy chairwoman of Suzhou Committee of Chinese Peasants’ and Workers’ Democratic Party; Hongmei Lin, deputy minister of Suzhou Industrial Park Publicity and United Front Work Department and director of the Municipal Bureau of Ethnic and Religious Affairs participated in the investigation and exchange activity.
See more
Successfully Concluded! RainMed Made a Stunning Appearance at High Tech Cardio 2023 Exhibition with Its Star Product caFFR
2023-02-09

Successfully Concluded! RainMed Made a Stunning Appearance at High Tech Cardio 2023 Exhibition with Its Star Product caFFR

From February 1st to 3rd, 2023, the offline exhibition of High Tech Cardio Conference was grandly held at Palais du Pharo in Marseille, France. As one of the most prestigious exhibitions in Europe for sharing and exchanging cutting-edge technology and clinical treatment research of interventional cardiology, the exhibition has attracted many high-tech medical device companies and top European experts from all over the world. Exhibitors included medical device giants such as Abbott, Boston Scientific, Edwards LifeSciences, Medtronic and Philips. As a Chinese innovative company, RainMed was invited, showing the unique technical charm of its product caFFR.
See more
Strong Alliance! RainMed will Be Collaborating with Corrib Core Lab in Ireland to Carry Out a Coronary Clinical Trial
2023-02-03

Strong Alliance! RainMed will Be Collaborating with Corrib Core Lab in Ireland to Carry Out a Coronary Clinical Trial

RainMed, an innovative medical device company from China, will collaborate with CORRIB Research Centre for Advanced Imaging and Core laboratory at University of Galway, Ireland, to carry out a coronary clinical trial. In the clinical trial, researchers will test caFFR, a coronary angiography-derived fractional flow reserve measurement system.
See more
High Tech 2023丨RainMed
2023-01-06

High Tech 2023丨RainMed's caFFR will be present at French Congress of Cardiovascular Diseases

RainMed’s caFFR will be exhibited at the offline exhibition of High Tech Cardio in Palais du Pharo, Marseille, France From February 1st to 3rd , 2023. High Tech is a professional congress gathering top interventional cardiology experts from France and the European Society of Cardiology to share cutting-edge technologies and clinical treatment research of interventional cardiology. It attracts top European experts and scholars, as well as major medical device enterprises on interventional cardiology treatment every year.
See more
The First Chinese Expert Consensus on Clinical Pathways of Coronary Artery Computational Physiology Detection Indicators was Officially Released, Promoting the Development of Coronary Function Evaluation to a New Level!
2022-12-30

The First Chinese Expert Consensus on Clinical Pathways of Coronary Artery Computational Physiology Detection Indicators was Officially Released, Promoting the Development of Coronary Function Evaluation to a New Level!

Recently, led by Academician Junbo Ge from Fudan University Zhongshan Hospital, Professor Yong Huo from Peking University First Hospital and supported by domestic independent innovation enterprise RainMed Medical, Chinese Expert Consensus on Clinical Pathways of Coronary Artery Computational Physiology Detection Indicators (hereinafter referred to as "Consensus") was officially released on the bank of Huangpu River. It took more than 7 months from the drafting to the release, innovatively included RainMed’s caFFR and caIMR into studies, and made detailed descriptions of their operating norms and application scopes, which provides practical guidelines for clinical use of coronary function evaluation, and creates an open market space for RainMed Medical’s coronary functional series products.
See more
RainMed Won a Series of Industry Awards, Creating a New Situation for Precision Medicine in Interventional Cardiology
2022-12-23

RainMed Won a Series of Industry Awards, Creating a New Situation for Precision Medicine in Interventional Cardiology

Recently, Suzhou RainMed Medical Technology Co., Ltd. frequently obtained the recognition of industry authority , showing its excellent comprehensive strength and leading advantage in research and development level and innovation as well as business layout.
See more
New Progress Has Been Made in the Clinical Study of RainMed’s caIMR System: It Can Independently Predict the Prognostic Value of Overweight Patients with Chronic Coronary Syndrome , and Improve the Global Epidemic Management Level
2022-12-16

New Progress Has Been Made in the Clinical Study of RainMed’s caIMR System: It Can Independently Predict the Prognostic Value of Overweight Patients with Chronic Coronary Syndrome , and Improve the Global Epidemic Management Level

Recently, a team from Tenth People’s Hospital of Tongji University published a clinical research paper -- "Prognostic impact of coronary microvascular dysfunction assessed by caIMR in overweight with chronic coronary syndrome patients" in an internationally renowned SCI journal. It is a groundbreaking study on the impact of coronary microvascular dysfunction in patients with overweight and chronic coronary syndrome (CCS). Results show that as the world's first non-interventional microcirculatory function diagnostic product, RainMed’s caIMR is an independent predictor of MACE in overweight patients with CCS which offers objective risk stratification for obese patients. This conclusion broadens the clinical application scenario of caIMR system, helps promote the process of epidemic management in China, and creates a new opportunity for large-scale clinical application of caIMR.
See more
RainMed Medical was Nominated for the 4th Chip Award for Its Innovation in Medical Device!
2022-12-09

RainMed Medical was Nominated for the 4th Chip Award for Its Innovation in Medical Device!

Recently, the 11-month fourth "Chip Award" of China Health Care Innovation Platform 2022 was officially held in Shanghai. After rigorous screening by more than 80 authoritative experts, RainMed Medical passed the test and stood out in nearly 300 innovative projects. Together with Innovent, RemeGen, Hutchison Pharmaceuticals and other leading enterprises in the industry, RainMed Medical won the "Medical Device Innovation Chip Award Nomination Award". This award highlights the superb product innovation ability and marketing of RainMed Medical, which is highly competitive in the industry.
See more
The 17th Zunyi Cardiovascular Conference | RainMed Medical· Forum on Coronary Function was Successfully Held
2022-12-02

The 17th Zunyi Cardiovascular Conference | RainMed Medical· Forum on Coronary Function was Successfully Held

On November 19th, 2022, RainMed Medical successfully held a forum on coronary function in the 17th academic conference on Cardiovascular Disease Diagnosis and Treatment Guidelines and Standardized Diagnosis and Treatment Training (Zunyi Cardiovascular Conference)-- Coronary Innovation Forum. In order to popularize the concept of functional diagnosis and promote the clinical application of the calculation of coronary physiological indicators, the forum invited famous experts in the field of cardiovascular disease in China, introduced the latest progress of coronary function, shared the clinical application of innovative computational coronary physiological indicators caFFR and caIMR, and imparted the application skills.
See more
The First Clinical Study Results of RainMed
2022-11-18

The First Clinical Study Results of RainMed's caFFR at Heart Centre in Southeast Asia were published! caFFR-guided Deferral of PCI was Safe and Comparable to Wired-based FFR Guidance!

Recently, Dr. Chandan Deepak Bhavnani from Pusat Jantung Sarawak and president of National Heart Association of Malaysia Dr. Alan Yean Yip Dr Fong's team published results of a clinical trial using coronary angiography-derived fractional flow reserve measurement system caFFR. The paper was published in Journal of Asian Pacific Society of Cardiology (JAPSC). This was the first study of its kind in Southeast Asia. Based on previous trials, this trial advances the clinical significance of caFFR value for intermediate coronary artery stenosis. The results showed that caFFR had a good agreement with wire-based FFR. The 12-month outcomes showed that caFFR-guided deferral of PCI was safe and comparable to wired-based FFR guidance.
See more
RainMed Actively Responds to Financial Discount Interest Policy! Its Integrated Diagnosis and Treatment Plan of Vascular Diseases Promotes the Homogenization of the Diagnosis and Treatment Level Among Regions
2022-11-11

RainMed Actively Responds to Financial Discount Interest Policy! Its Integrated Diagnosis and Treatment Plan of Vascular Diseases Promotes the Homogenization of the Diagnosis and Treatment Level Among Regions

Recently, there is a bunch of good news in the field of medical device. A few days ago, the State Council executive meeting decided to use special re-loans and financial discount interest to support the renovation of equipment in some areas, increase market demand, and increase the development momentum. At the same time, the National Health Commission also issued a notice of upgrading medical device with financial discount loans. This policy will surely stimulate the vitality of hospital procurement and promote domestic innovative medical devices to grow with vigorous market vitality
See more
GW-ICC 2022 | RainMed Medical Successfully Held a Satellite Symposium on Computational Coronary Physiology
2022-11-04

GW-ICC 2022 | RainMed Medical Successfully Held a Satellite Symposium on Computational Coronary Physiology

On October 29th, 2022, during the 33rd Great Wall International Congress of Cardiology, Asia Heart Society Congress 2022, in order to popularize the concept of coronary functional evaluation and promote the clinical application of computational coronary physiological indicators, RainMed Medical successfully held a satellite symposium of computational coronary physiology. The well-known experts in the field of cardiovascular were invited, and they discussed and prospected the latest progress of coronary functional evaluation technology, and shared the clinical experience of innovative computational physiology indicators caFFR and caIMR. It is worth noting that it is the first time that RainMed shared clinical cases of caIMR in satellite symposiums in such a national academic congress, which has attracted widespread attention and aroused heated discussion among participants.
See more
Exhibition is Underway! RainMed
2022-10-28

Exhibition is Underway! RainMed's caFFR Unveiled for the First Time at the 18th Malaysian Cardiovascular Intervention Symposium

RainMed's caFFR Unveiled for the First Time at the 18th Malaysian Cardiovascular Intervention Symposium
See more
The Vice Minister Wenpu Ma and Academician Yan Shen Visited RainMed Medical for Inspection and Guide the Development of Domestic Innovative Medical Devices
2022-10-21

The Vice Minister Wenpu Ma and Academician Yan Shen Visited RainMed Medical for Inspection and Guide the Development of Domestic Innovative Medical Devices

Recently, Mr. Wenpu Ma, former vice minister of the International Department of Central Committee of CPC, Former Vice Director of the 11th NPC Foreign Affairs Committee, and Professor Yan Shen, former vice chairman of China Association for Science and Technology (CAST), former deputy of National Natural Science Foundation of China and member of Chinese Academy of Sciences and the other two people visited Beijing office of RainMed Medical and fully affirmed the achievements of RainMed Medical in scientific and technological innovation. Mr. Kangjian Liu, Vice President and Secretary of the Board of Directors of RainMed and Mr. Liang Wan, Director of Government Affairs Department, accompanied them during the visit.
See more
Good News! RainMed
2022-10-14

Good News! RainMed's caFFR System Has Been Successfully Certified by Australian TGA, Unlocking a New Area in Overseas Market!

On September 29th, 2022, RainMed Medical Co., LTD. (Stock Code: 2297.HK, hereinafter referred to as "RainMed") officially announced that its caFFR system has been successfully approved by Australian Government Department of Health Therapeutic Goods Administration(TGA), unlocking a new area in overseas market. Having got TGA’s recognition means RainMed has taken a solid step in accelerating its layout of international marketing system!
See more
TCT 2022丨RainMed caIMR Presented at the Transcatheter Cardiovascular Therapeutics Conference, Providing a New Solution for Global Coronary Microcirculation Function Assessment
2022-09-30

TCT 2022丨RainMed caIMR Presented at the Transcatheter Cardiovascular Therapeutics Conference, Providing a New Solution for Global Coronary Microcirculation Function Assessment

RainMed Medical, an innovative medical device enterprise from China, was invited to deliver a speech at TCT to announce its latest clinical trial data because of the original breakthrough technology of caIMR in coronary microcirculation function assessment, which showed the world China's local innovation strength.
See more
2022 China Medical Device Outbound Conference | RainMed’s caIMR Series Won the Award of "2022 Most Innovative Outbound Medical Devices", Which Will Further Demonstrate the Infinite Charm of China’s Smart Manufacturing on the Global Stage
2022-09-23

2022 China Medical Device Outbound Conference | RainMed’s caIMR Series Won the Award of "2022 Most Innovative Outbound Medical Devices", Which Will Further Demonstrate the Infinite Charm of China’s Smart Manufacturing on the Global Stage

In September 2022, RainMed Medical was invited to participate in the 2022 China Medical Device Outbound Conference hosted by the International Health Exchange and Cooperation Center NHC PRC (IHECC) and VBDATA.CN.
See more
2022CHC·Surgical Robot Forum: RainMed Medical Announced to Build Its Own Vascular Interventional Surgery Robot to Promote the Realization of Unmanned Operating Room
2022-09-08

2022CHC·Surgical Robot Forum: RainMed Medical Announced to Build Its Own Vascular Interventional Surgery Robot to Promote the Realization of Unmanned Operating Room

On September 1st, 2022, the "2022CHC·Citic Securities Healthcare Conference and the 11th China MedTec CEO Summit" jointly hosted by CHC Healthcare Consulting and Citic Securities, was held in Hefei, Anhui Province. The conference focused on cutting-edge research and held a special forum on surgical robots. As the strategic partner of the conference and the leader of the vascular interventional surgery robot field, RainMed Medical was invited to attend the forum. Mr. Kangjian Liu, Vice president and Secretary of the Board announced that RainMed Medical will build a platform-level vascular interventional surgery robot to promote the realization of an unmanned operating room with automated diagnosis and treatment.
See more
RainMed Medical Satellite Symposium Has been Successfully Held During the 21st Cardiovascular Disease Academic Conference of Shanxi Medical Association
2022-09-02

RainMed Medical Satellite Symposium Has been Successfully Held During the 21st Cardiovascular Disease Academic Conference of Shanxi Medical Association

On August 27, 2022, during the 21st Cardiovascular Disease Academic Conference of Shanxi Medical Association, RainMed Medical successfully held a satellite symposium in order to popularize the clinical application of calculating coronary physiological indicators and promote precise interventional treatment of coronary heart disease. Renowned experts in the field of cardiovascular diseases were invited to discuss the latest progress of coronary functional evaluation technology and the clinical application of innovative functional indicators caFFR and caIMR.
See more
The Kick-off Meeting of "Expert Consensus on Clinical Pathways of Coronary Artery Computational Physiology Testing Indicators in China" Led by Academician Junbo Ge and Supported by RainMed Medical Was Held in Anhui Province
2022-08-26

The Kick-off Meeting of "Expert Consensus on Clinical Pathways of Coronary Artery Computational Physiology Testing Indicators in China" Led by Academician Junbo Ge and Supported by RainMed Medical Was Held in Anhui Province

On August 20, 2022, during the fourth Confucianism and Taoism International Congress of Cardiology (CTCC), the kick-off meeting of "Expert Consensus on Clinical Pathways of Coronary Artery Computational Physiology Testing Indicators in China", led by Academician Junbo Ge from Fudan University Zhongshan Hospital and supported by RainMed Medical, was held in Anhui province.
See more
Strategic Cooperation | RainMed Medical and Angiotec Signed a Strategic Cooperation Agreement to Accelerate the Development of Integrated Solutions for Cardiovascular Operating Rooms
2022-08-19

Strategic Cooperation | RainMed Medical and Angiotec Signed a Strategic Cooperation Agreement to Accelerate the Development of Integrated Solutions for Cardiovascular Operating Rooms

On August 16, 2022, RainMed Medical Co., LTD. (hereinafter referred to as "RainMed", stock code: 2297.HK) and Angiotec (Tianjin)Technology Co., Ltd. (hereinafter referred to as "Angiotec”) held a signing ceremony for strategic cooperation in Tianjin. Mr. Yunfei Huo, Chairman of the Board, Executive Director and Chief Executive Officer of RainMed and Mr. Da Zhuo, General Manager of Angiotec signed the agreement on behalf of both companies. Mr. Yonghui Lv, Executive Director and co-Chief Executive Officer of RainMed also attended the meeting.
See more
Initial Release of caIMR
2022-08-12

Initial Release of caIMR's Clinical Application Potential! RainMed’s caIMR Empowered the development of clinical treatment strategies, adding strong evidence for the concept of "intervention without implantation" for STEMI patients

Recently, Professor Zhirong Wang's team from The Affiliated Hospital of Xuzhou Medical University published a paper in SCI journal titled "Computational Pressure-Fluid Dynamics Applied to Index of Microcirculatory Resistance, Predicting the Prognosis of Drug-Coated Balloons Compared With Drug-Coated Balloons Compared With Drug-Eluting Stents in STEMI Patients". The paper indicates that RainMed’s caIMR can independently predict the likelihood of cardiac death or readmission due to heart failure in STEMI patients. At the same time, caIMR confirmed that the effect of drug-coated balloon (DCB) therapy is not inferior to drug-eluting stent (DES) in the diagnosis and treatment of STEMI by accurately diagnosing the damage of coronary microcirculation. It has added strong clinical evidence for the advanced diagnosis and treatment concept of "intervention without implantation" in STEMI patients and assisted clinical development of better interventional diagnosis and treatment strategy.
See more
18th YRICC | RainMed Medical Satellite Symposium Has Been Successfully Held
2022-07-29

18th YRICC | RainMed Medical Satellite Symposium Has Been Successfully Held

On July 22nd, 2022, during the 18th Yellow River International Cardiology Conference (YRICC 2022), RainMed Medical successfully held a satellite symposium. Renowned cardiovascular experts from all over the country had a heated discussion on research progress, clinical significance and application scenarios of caFFR and caIMR.
See more
Previous page
1
2
3

CONTACT US

0512-62622215

Address: Building 31, Northeast District, Nano City, No. 99 Jinji Lake Avenue, Suzhou industrial park

这是描述信息

WeChat public account

这是描述信息

Recruitment QR Code

We use cookies to improve our site and your shopping experience. By continuing to browse our site you accept our cookie policy. Find out more
close

Page Copyright© 2021- Suzhou Rainmed Medical Technology Co., Ltd.  苏公网安备32059002003601号  (苏)-非经营性-2021-0149